Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Equity Bottom-Up

<ul>
<li>Back in June 2017, <a href="https://www.smartkarma.com/entities/toray-industries-inc" target="_blank" data-smartkarma-citation="entities:625:1" rel="noopener">Toray Industries (3402 JP)</a> acquired a 28.03% stake in <a href="https://www.smartkarma.com/entities/pacific-textiles-holdings" target="_blank" data-smartkarma-citation="entities:12638:1" rel="noopener">Pacific Textiles (1382 HK)</a> (@ HK$10/share). Rumours that Toray would take this stake to 50% never unfolded.</li>
<li>Pacific Textiles is currently trading at HK$1.30/share, its lowest level outside of the GFC. </li>
<li>Relatively inexpensive, high digit yield and M&amp;A angle, Pacific Textiles remains attractive. This is supported by the recent Offer for <a href="https://www.smartkarma.com/entities/weiqiao-textile-co" target="_blank" data-smartkarma-citation="entities:3690:1" rel="noopener">Weiqiao (2698 HK)</a> and David Webb taking a 5% stake. </li>
</ul>


Back in June 2017, Toray Industries (3402 JP) acquired a 28.03% stake in Pacific Textiles (1382 HK) (@ HK$10/share). Rumours that Toray would take this stake to 50% never unfolded.
Pacific Textiles is currently trading at HK$1.30/share, its lowest level outside of the GFC. 
Relatively inexpensive, high digit yield and M&amp;A angle, Pacific Textiles remains attractive. This is supported by the recent Offer for Weiqiao (2698 HK) and David Webb taking a 5% stake. 


Pacific Textiles (1382 HK): Material Benefits

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/shanghai-fosun-pharmaceutical-group" target="_blank" data-smartkarma-citation="entities:8045:1" rel="noopener">Shanghai Fosun Pharmaceutical (Group) (2196 HK)</a>'s (SFP) "Merger by Absorption" <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0624/2024062401217.pdf" target="_blank" rel="noopener">HK$24.60/share cash Offer</a> for H-shares not held in <a href="https://www.smartkarma.com/entities/shanghai-henlius-biotech-inc" target="_blank" data-smartkarma-citation="entities:27888:1" rel="noopener">Shanghai Henlius Biotech (2696 HK)</a>, tentatively includes a scrip alternative.</li>
<li>The first hurdle for the share option - valid letters of interest from those shareholders wishing to rollover - was <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0711/2024071100831.pdf" target="_blank" rel="noopener">secured yesterday</a>. SCP still has the discretion on providing scrip.</li>
<li>But if SFP had any lingering doubts whether to offer scrip, that was answered earlier this week with the emergence of a substantial shareholder who is typically a pre-IPO investor.</li>
</ul>



Shanghai Fosun Pharmaceutical (Group) (2196 HK)'s (SFP) "Merger by Absorption" HK$24.60/share cash Offer for H-shares not held in Shanghai Henlius Biotech (2696 HK), tentatively includes a scrip alternative.
The first hurdle for the share option - valid letters of interest from those shareholders wishing to rollover - was secured yesterday. SCP still has the discretion on providing scrip.
But if SFP had any lingering doubts whether to offer scrip, that was answered earlier this week with the emergence of a substantial shareholder who is typically a pre-IPO investor.


Henlius (2696 HK): Here Comes The Scrip Option

Canvest Environmental Protection Group / Event-Driven

<ul>
<li>Since waste-to-energy play <a href="https://www.smartkarma.com/entities/canvest-environmental-protection-group-co-ltd" target="_blank" data-smartkarma-citation="entities:100:1" rel="noopener">Canvest Environmental Protection (1381 HK)</a> announced a possible privatisation from <a href="https://www.smartkarma.com/entities/grandblue-environment-co-a" target="_blank" data-smartkarma-citation="entities:17887:1" rel="noopener">Grandblue Environment (600323 CH)</a> at $4.90/share (a 20.7% premium to undisturbed), shares are up just 6.4%. </li>
<li>There's a lot to pack in here, not the least being this is an indicative Pre-Conditional Offer.</li>
<li>But the fact the announcement mentions rolling over a specific number of shares of the controlling shareholders (7.23%), suggests negotiations are well advanced. So we explore.</li>
</ul>


Since waste-to-energy play Canvest Environmental Protection (1381 HK) announced a possible privatisation from Grandblue Environment (600323 CH) at $4.90/share (a 20.7% premium to undisturbed), shares are up just 6.4%. 
There's a lot to pack in here, not the least being this is an indicative Pre-Conditional Offer.
But the fact the announcement mentions rolling over a specific number of shares of the controlling shareholders (7.23%), suggests negotiations are well advanced. So we explore.


Canvest (1381 HK): Evaluating A Privatisation

<ul>
<li>
<a href="https://www.smartkarma.com/entities/shanghai-fosun-pharmaceutical-group" target="_blank" data-smartkarma-citation="entities:8045:1" rel="noopener">Shanghai Fosun Pharmaceutical (2196 HK)</a> has made a<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0624/2024062401217.pdf" target="_blank" rel="noopener"> HK$24.60/share Offer</a> (best &amp; final), in cash, for H-shares not held in <a href="https://www.smartkarma.com/entities/shanghai-henlius-biotech-inc" target="_blank" data-smartkarma-citation="entities:27888:1" rel="noopener">Shanghai Henlius Biotech (2696 HK)</a>. A scrip alternative may be afforded. </li>
<li>As Henlius is PRC-incorporated, this Offer is structured as a Merger by Absorption, involving a Scheme-like vote for independent H-shareholders. There is no tendering condition.
</li>
<li>Pre-Conditions include NDRC, MoC, and SAFE. The Long Stop date to secure these conditions is 30th April 2025. That's way too conservative. This should be wrapped up around mid 4Q24.</li>
</ul>



Shanghai Fosun Pharmaceutical (2196 HK) has made a HK$24.60/share Offer (best &amp; final), in cash, for H-shares not held in Shanghai Henlius Biotech (2696 HK). A scrip alternative may be afforded. 
As Henlius is PRC-incorporated, this Offer is structured as a Merger by Absorption, involving a Scheme-like vote for independent H-shareholders. There is no tendering condition.

Pre-Conditions include NDRC, MoC, and SAFE. The Long Stop date to secure these conditions is 30th April 2025. That's way too conservative. This should be wrapped up around mid 4Q24.


Henlius Biotech (2696 HK): Fosun Pharma's "Fair" Offer

<ul>
<li>For the month of March 2024, 8 new transactions (firm and non-binding) were discussed on Smartkarma with an overall announced deal size of ~US$4bn.</li>
<li>The average premium for the new transactions announced (or first discussed) in March was ~55%. The average premium YTD is ~39%.</li>
<li>This compares to the average premium for transactions in 2023 (117 transactions), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) of 39%, 41%, 33%, 31%, and 31% respectively.</li>
</ul>


For the month of March 2024, 8 new transactions (firm and non-binding) were discussed on Smartkarma with an overall announced deal size of ~US$4bn.
The average premium for the new transactions announced (or first discussed) in March was ~55%. The average premium YTD is ~39%.
This compares to the average premium for transactions in 2023 (117 transactions), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) of 39%, 41%, 33%, 31%, and 31% respectively.


(Mostly) Asia M&A, Mar 2024: Chilled & Frozen, TDCX, MMA Offshore, JSR, Roland DG, SciClone

China

Anhui Anli Material Technology Company Limited produces and sells middle and top grade PU synthetic leather. The Company's products include ecological functional PU synthetic leather and ordinary PU synthetic leather.

Anhui Anli Material Technology (300218 CH)

Shanghai Dragon Corp. manufactures and markets a variety of intimate apparel, underwear, textile products, and suits.  The Company also trades general merchandise.

FoShan Saturday Shoes Company Ltd. manufactures and designs footwear under its own brands. The Company also has its own research and development centers and professional design manufacturing plants.

Fujian Septwolves Industry Co Ltd designs, manufactures, and sells apparel and accessories.  The Company's main products are men's jackets, T shirts, and other casual products.

Luthai Textile Co., Ltd. operates in the textile industry.  The Company's products include yarns, grey cloth, dyed fabrics for shirts and other related products.

FIYTA Holdings Ltd. designs, manufactures, and markets watches and clocks. Its products include quartz watches, artistic clocks, scratch proof precious stone watches, and timing regulators. The Company also has operation in property rental business.

Shanghai Shuixing Home Textile Co., Ltd. operates as a household textile goods manufacturing company. The Company produces and sells blankets, bedspreads, sheets, table clothes, towels, and other related products. Shanghai Shuixing Home Textile markets its products throughout China.

Joeone Company Limited develops, designs, produces, sales and promotes their brand of trousers, jackets and other apparel products.  The Company's main products are men's business-casual wear.

Zhejiang Unifull Industrial Fiber Co., Ltd. develops, manufactures, and sells raw materials used in the textile industry.  The Company's products include industrial polyester filament and high-viscosity slices.

Zhejiang Unifull Industrial Fibre (002427 CH)

Lanzhou Sanmao Industrial Co., Ltd. manufactures and markets woolen fabrics.

Kewal Kiran Clothing Ltd. manufactures clothing.  The Company production include men's jeans, shirts, T-shirts, jackets, and trousers.

Texhong Textile Group Limited manufactures and sells yarn and grey fabrics. The Company's main focus is promoting and selling spandex stretch yarn and spandex stretch grey fabrics.

Taiwan Paiho Limited manufactures and markets a variety of fastening tapes used for clothes and shoe products, elastic cords and bands, lace products, and knit fabrics for use in apparel.

The Japan Wool Textile Co., Ltd. (Nikke Group) manufactures and sells woolen textiles for school uniforms, fashion and business attire, and a variety of other apparel and non-apparel goods. The Company also produces woven materials, thread and yarn for weaving and knitting, fire-resistant clothing for firefighters, and non-wool related products. Nikke operates in Japan.

Vaibhav Global Limited manufactures and exports jewelry. The Company processes rough gemstones into finished pieces and exports much of its production of colored gemstones and studded jewelry. Vaibhav Global ventured into the international retail market by setting up retail stores at major tourist destinations like Alaska and Caribbean.

Movado Group, Inc. designs, manufactures, retails, and distributes watches as well as jewelry, tabletop, and accessory products.  The Company markets several watch brands in North America, Western Europe, and the Far East.

ONWARD HOLDINGS CO., LTD. manufactures men's ready-made suits, women's, and children's wear.  The Company has its own brands, Onward and KUMIKYOKU. Onward also manufactures sports goods, books, stationery, cosmetics, art decoration.

Bombay Dyeing and Manufacturing Company Ltd. manufactures cotton textiles and non-woven fabrics. The Company also manufactures yarn and DMT, which is a raw material used for manufacturing polyester. The Company is also involved in real estate activities as part of their operations.

Gunze Ltd manufactures underwear, socks, outerwear, and other textile. The Company also manufactures functional materials such as plastic films, electronic materials, engineering plastics, printing machinery.  Gunze operates real estate.

Citychamp Watch & Jewellery Group Limited, through its subsidiaries, manufactures and distributes watches, timepieces and enamelled copper wires. The Company also invests in and develops properties.

Weiqiao Textile Company Limited, through its subsidiaries, produces, sells, and distributes cotton yarn, grey fabric and denim.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Weiqiao Textile Co (2698 HK)

Pacific Textiles (1382 HK): Material Benefits

The key factors which made Pacific Textiles attractive previously (value, solid dividend, M&A angle) remain intact. If small-cap names are your...

David Blennerhassett

Henlius (2696 HK): Here Comes The Scrip Option

This is trading wide-ish at 8.8%/28.8% currently (assuming mid-Nov payment), ostensibly due to the timing on the regulatory approvals - TCM (570...

David Blennerhassett

Canvest (1381 HK): Evaluating A Privatisation

I'd get involved in Canvest around here and on any weakness. Caveat - this is still an indicative pre-conditional Offer.

David Blennerhassett

Henlius Biotech (2696 HK): Fosun Pharma's "Fair" Offer

I'd be buying Henlius up to around $23.30 or a gross/annualised spread of 5%/15%, assuming early mid-November completion.

David Blennerhassett

(Mostly) Asia M&A, Mar 2024: Chilled & Frozen, TDCX, MMA Offshore, JSR, Roland DG, SciClone

For the month of March, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$4bn. The average premium for the new deals...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)